CVEvulnerability

CVE-2022-43557

5.3 MEDIUM Published 2022-12-05 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2022-12-05
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
5.3 MEDIUM — CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
CVSS 3.1 ([email protected])
5.3 MEDIUM — CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:H
Weaknesses
CWE-1299, CWE-287

Description

The BD BodyGuard™ infusion pumps specified allow for access through the RS-232 (serial) port interface. If exploited, threat actors with physical access, specialized equipment and knowledge may be able to configure or disable the pump. No electronic protected health information (ePHI), protected health information (PHI) or personally identifiable information (PII) is stored in the pump.

Affected configurations

• bd bodyguard 999-603 firmware • bd bodyguard duo 999-903 firmware • bd bodyguard epidural 999-683 firmware • bd bodyguard pain manager 999-803 firmware • bd bodyguard t 999-103 firmware • bd bodyguard 323 colorvision firmware • bd bodyguard 121 twins firmware

Related

Weakness · CWE (2)

  • CWE-1299 Missing Protection Mechanism for Alternate Hardware Interface weakness
  • CWE-287 Improper Authentication weakness

References